Advertisement

Topics

FDA OKs Teduglutide for Children With Short Bowel Syndrome

11:46 EDT 17 May 2019 | Medscape

Teduglutide is the only glucagon-like peptide-2 analog approved that improves intestinal absorption in patients with short bowel syndrome who are dependent on parenteral support.
FDA Approvals

Original Article: FDA OKs Teduglutide for Children With Short Bowel Syndrome

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Teduglutide for Children With Short Bowel Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement